CollPlant Biotechnologies Ltd

CLGNNASDAQ · USD
4.64USD+4.30 (0.00%)
512

CollPlant Biotechnologies Ltd (CLGN) Covered Calls

Read more

Running CLGN covered calls helps you generate income from CollPlant Biotechnologies Ltd shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best CLGN covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call pairs limited risk with a clear income profile. If CLGN stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling CLGN covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given CLGN covered call is worth writing.

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds.

No illustrative rows to display.

As of Nov 16, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV Rank71.03% High
  • Market cap (M$)6
  • 52 weeks high-89.31%
  • 52 weeks low30.77%
  • Analyst recommendationHold
    3.00
  • Target price$12.00
    158.62% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-12-02
  • P/E—
  • Future P/E—
  • EPS (ttm)-1.03
  • EPS growth next 5 years—

As of Nov 16, 2026